Sub-cellular targeting of constitutive NOS in health and disease

Journal of Molecular and Cellular Cardiology

Volumn 52, Issue 2, 2012, Pages 341-350

  Zhang, Yin Hua ^a   Casadei, Barbara ^b  

^a Seoul National University   (South Korea)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Compartmentalization; ENOS; Myocardial function; NNOS; Signaling

Indexed keywords

BETA 3 ADRENERGIC RECEPTOR; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC GMP; ENDOTHELIAL NITRIC OXIDE SYNTHASE; NEURONAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE; PHOSPHOLAMBAN;

ATHEROSCLEROSIS; CALCIUM CURRENT; CARDIOVASCULAR DISEASE; CELLULAR DISTRIBUTION; DIABETES MELLITUS; ENDOTHELIAL NITRIC OXIDE SYNTHASE GENE; ENZYME ACTIVITY; ENZYME LOCALIZATION; ENZYME REGULATION; ENZYME STRUCTURE; EXCITATION CONTRACTION COUPLING; GENE; GENE OVEREXPRESSION; HEART ARRHYTHMIA; HEART FUNCTION; HEART INFARCTION; HEART LEFT VENTRICLE COMPLIANCE; HEART LEFT VENTRICLE PRESSURE; HEART MUSCLE; HUMAN; HYPERTENSION; INOTROPISM; MOLECULAR MECHANICS; NEURONAL NITRIC OXIDE SYNTHASE GENE; NITROSYLATION; NONHUMAN; OXIDATION REDUCTION STATE; PARASYMPATHETIC TONE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; UPREGULATION;

ANIMALS; CARDIOVASCULAR DISEASES; GENE EXPRESSION; HUMANS; INTRACELLULAR SPACE; MYOCARDIUM; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; OXIDATION-REDUCTION; SIGNAL TRANSDUCTION;

MURINAE; MUS;

EID: 84855994111     PISSN: 00222828     EISSN: 10958584     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2011.09.006     Document Type: Review

References (95)

1. Furchgott R.F., Zawadzki J.V. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980, 288:373-376.
2. Xu K.Y., Huso D.L., Dawson T.M., Bredt D.S., Becker L.C. Nitric oxide synthase in cardiac sarcoplasmic reticulum. Proc Natl Acad Sci U S A 1999, 96:657-662.
3. Ward M.E., Toporsian M., Scott J.A., Teoh H., Govindaraju V., Quan A., et al. Hypoxia induces a functionally significant and translationally efficient neuronal NO synthase mRNA variant. J Clin Invest 2005, 115:3128-3139.
4. Massion P.B., Feron O., Dessy C., Balligand J.-L. Nitric oxide and cardiac function: ten years after, and continuing. Circ Res 2003, 93:388-398.
5. Seddon M., Shah A.M., Casadei B. Cardiomyocytes as effectors of nitric oxide signalling. Cardiovasc Res 2007, 75:315-326.
6. Pinsky D.J., Patton S., Mesaros S., Brovkovych V., Kubaszewski E., Grunfeld S., et al. Mechanical transduction of nitric oxide synthesis in the beating heart. Circ Res 1997, 81:372-379.
7. Prendergast B.D., Sagach V.F., Shah A.M. Basal release of nitric oxide augments the Frank-Starling response in the isolated heart. Circulation 1997, 96:1320-1329.
8. 2+ release in cardiomyocytes. Nat Cell Biol 2001, 3:867-873.
9. Khan S.A., Skaf M.W., Harrison R.W., Lee K., Minhas K.M., Kumar A., et al. Nitric oxide regulation of myocardial contractility and calcium cycling: independent impact of neuronal and endothelial nitric oxide synthases. Circ Res 2003, 92:1322-1329.
10. Wang H., Kohr M.J., Traynham C.J., Wheeler D.G., Janssen P.M.L., Ziolo M.T. Neuronal nitric oxide synthase signaling within cardiac myocytes targets phospholamban. Am J Physiol Cell Physiol 2008, 294:C1566-C1575.
11. Ashley E.A., Sears C.E., Bryant S.M., Watkins H.C., Casadei B. Cardiac nitric oxide synthase 1 regulates basal and beta-adrenergic contractility in murine ventricular myocytes. Circulation 2002, 105:3011-3016.
12. Cotton J.M., Kearney M.T., MacCarthy P.A., Grocott-Mason R.M., McClean D.R., Heymes C., et al. Effects of nitric oxide synthase inhibition on Basal function and the force-frequency relationship in the normal and failing human heart in vivo. Circulation 2001, 104:2318-2323.
13. Feron O., Belhassen L., Kobzik L., Smith T.W., Kelly R.A., Michel T. Endothelial nitric oxide synthase targeting to caveolae. Specific interactions with caveolin isoforms in cardiac myocytes and endothelial cells. J Biol Chem 1996, 271:22810-22814.
14. Williams J.C., Armesilla A.L., Mohamed T.M.A., Hagarty C.L., McIntyre F.H., Schomburg S., et al. The sarcolemmal calcium pump, a-1 syntrophin, and neuronal nitric-oxide synthase are parts of a macromolecular protein complex. J Biol Chem 2006, 281:23341-23348.
15. Kinugawa S., Huang H., Wang Z., Kaminski P.M., Wolin M.S., Hintze T.H. A defect of neuronal nitric oxide synthase increases xanthine oxidase-derived superoxide anion and attenuates the control of myocardial oxygen consumption by nitric oxide derived from endothelial nitric oxide synthase. Circ Res 2005, 96:355-362.
16. Khan S.A., Lee K., Minhas K.M., Gonzalez D.R., Raju S.V., Tejani A.D., et al. Neuronal nitric oxide synthase negatively regulates xanthine oxidoreductase inhibition of cardiac excitation-contraction coupling. Proc Natl Acad Sci U S A 2004, 101:15944-15948.
17. 2+ channel alpha1 subunit and reduced ischemia/reperfusion injury. Circ Res 2006, 98:403-411.
18. Damy T., Ratajczak P., Shah A.M., Camors E., Marty I., Hasenfuss G., et al. Increased neuronal nitric oxide synthase-derived NO production in the failing human heart. Lancet 2004, 363:1365-1367.
19. Bendall J.K., Damy T., Ratajczak P., Loyer X., Monceau V., Marty I., et al. Role of myocardial neuronal nitric oxide synthase-derived nitric oxide in beta-adrenergic hyporesponsiveness after myocardial infarction-induced heart failure in rat. Circulation 2004, 110:2368-2375.
20. Feng Y., Venema V.J., Venema R.C., Tsai N., Caldwell R.B. VEGF induces nuclear translocation of Flk-1/KDR, endothelial nitric oxide synthase, and caveolin-1 in vascular endothelial cells. Biochem Biophys Res Commun 1999, 256:192-197.
21. Grasselli A., Nanni S., Colussi C., Aiello A., Benvenuti V., Ragone G., et al. Estrogen receptor-alpha and endothelial nitric oxide synthase nuclear complex regulates transcription of human telomerase. Circ Res 2008, 103:34-42.
22. Martinez-Moreno M., Alvarez-Barrientos A., Roncal F., Albar J.P., Gavilanes F., Lamas S., et al. Direct interaction between the reductase domain of endothelial nitric oxide synthase and the ryanodine receptor. FEBS Lett 2005, 579:3159-3163.
23. Paulus W.J., Vantrimpont P.J., Shah A.M. Paracrine coronary endothelial control of left ventricular function in humans. Circulation 1995, 92:2119-2126.
24. 2+ in intact cardiac myocytes. Circ Res 1994, 74:970-978.
25. Layland J., Li J.-M., Shah A.M. Role of cyclic GMP-dependent protein kinase in the contractile response to exogenous nitric oxide in rat cardiac myocytes. J Physiol (Lond) 2002, 540:457-467.
26. Gyurko R., Kuhlencordt P., Fishman M.C., Huang P.L. Modulation of mouse cardiac function in vivo by eNOS and ANP. Am J Physiol 2000, 278:H971-H981.
27. Han X., Shimoni Y., Giles W.R. An obligatory role for nitric oxide in autonomic control of mammalian heart rate. J Physiol (Lond) 1994, 476.2:309-314.
28. Han X., Kubota I., Feron O., Opel D.J., Arstall M.A., Zhao Y.-Y., et al. Muscarinic cholinergic regulation of cardiac myocyte ICa-L is absent in mice with targeted disruption of endothelial nitric oxide synthase. Proc Natl Acad Sci U S A 1998, 95:6510-6515.
29. Martin S.R., Emanuel K., Sears C.E., Zhang Y.H., Casadei B. Are myocardial eNOS and nNOS involved in the beta-adrenergic and muscarinic regulation of inotropy? A systematic investigation. Cardiovasc Res 2006, 70:97-106.
30. Gödecke A., Decking U.K.M., Ding Z., Hirchenhain J., Bidmon H.-J., Godecke S., et al. Coronary hemodynamics in endothelial NO synthase knockout mice. Circ Res 1998, 82:186-194.
31. Gödecke A., Heinicke T., Kamkin A., Kiseleva I., Strasser R.H., Decking U.K.M., et al. Inotropic response to β-adrenergic receptor stimulation and anti-adrenergic effect of ACh in endothelial NO synthase-deficient mouse hearts. J Physiol (Lond) 2001, 532:195-204.
32. Vandecasteele G., Eschenhagen T., Scholz H., Stein B., Verde I., Fischmeister R. Muscarinic and β-adrenergic regulation of heart rate, force of contraction and calcium current is preserved in mice lacking endothelial nitric oxide synthase. Nat Med 1999, 5:331-334.
33. 2+ current is not altered in cardiac ventricular myocytes from mice lacking endothelial nitric oxide synthase. J Physiol (Lond) 2000, 528:279-289.
34. Massion P.B., Dessy C., Desjardins F., Pelat M., Havaux X., Belge C., et al. Cardiomyocyte-restricted overexpression of endothelial nitric oxide synthase (NOS3) attenuates beta-adrenergic stimulation and reinforces vagal inhibition of cardiac contraction. Circulation 2004, 110:2666-2672.
35. Champion H.C., Georgakopoulos D., Takimoto E., Isoda T., Wang Y., Kass D.A. Modulation of in vivo cardiac function by myocyte-specific nitric oxide synthase-3. Circ Res 2004, 94:657-663.
36. Takimoto E., Champion H.C., Belardi D., Moslehi J., Mongillo M., Mergia E., et al. cGMP catabolism by phosphodiesterase 5A regulates cardiac adrenergic stimulation by NOS3-dependent mechanism. Circ Res 2005, 96:100-109.
37. 2+ current in cardiac myocytes. J Mol Cell Cardiol 2009, 47:304-314.
38. Sears C.E., Bryant S.M., Ashley E.A., Lygate C.A., Rakovic S., Wallis H.L., et al. Cardiac neuronal nitric oxide synthase isoform regulates myocardial contraction and calcium handling. Circ Res 2003, 92:52e-59e.
39. Dawson D., Lygate C.A., Zhang M.H., Hulbert K., Neubauer S., Casadei B. nNOS gene deletion exacerbates pathological left ventricular remodeling and functional deterioration after myocardial infarction. Circulation 2005, 112:3729-3737.
40. Barouch L.A., Harrison R.W., Skaf M.W., Rosas G.O., Cappola T.P., Kobeissi Z.A., et al. Nitric oxide regulates the heart by spatial confinement of nitric oxide synthase isoforms. Nature 2002, 416:337-340.
41. Wang H., Viatchenko-Karpinski S., Sun J., Gyorke I., Benkusky N.A., Kohr M.J., et al. Regulation of myocyte contraction via neuronal nitric oxide synthase: role of ryanodine receptor S-nitrosylation. J Physiol 2010, 588:2905-2917.
42. Burger D.E., Lu X., Lei M., Xiang F.-L., Hammoud L., Jiang M., et al. Neuronal nitric oxide synthase protects against myocardial infarction-induced ventricular arrhythmia and mortality in mice. Circulation 2009, 120:1345-1354.
43. Schuh K., Uldrijan S., Telkamp M., Rothlein N., Neyses L. The plasmamembrane calmodulin-dependent calcium pump: a major regulator of nitric oxide synthase I. J Cell Biol 2001, 155:201-206.
44. Mohamed T.M.A., Oceandy D., Prehar S., Alatwi N., Hegab Z., Baudoin F.M., et al. Specific role of neuronal nitric-oxide synthase when tethered to the plasma membrane calcium pump in regulating the beta-adrenergic signal in the myocardium. J Biol Chem 2009, 284:12091-12098.
45. Gonzalez D.R., Beigi F., Treuer A.V., Hare J.M. Deficient ryanodine receptor S-nitrosylation increases sarcoplasmic reticulum calcium leak and arrhythmogenesis in cardiomyocytes. Proc Natl Acad Sci U S A 2007, 104:20612-20617.
46. Meszaros L.G. Nitric oxide and the ryanodine receptor Ca-release channel. Circ Res 2010, 107:e1.
47. Hess D.T., Stamler J.S. Reply to Meszaros: S-nitrosylation of the RyR in health and disease. Circ Res 2010, 107:e2-e3.
48. Zhang Y.H., Zhang M.H., Sears C.E., Emanuel K., Redwood C., El-Armouche A., et al. Reduced phospholamban phosphorylation is associated with impaired relaxation in left ventricular myocytes from neuronal NO synthase-deficient mice. Circ Res 2008, 102:242-249.
49. Saraiva R.M., Minhas K.M., Raju S.V.Y., Barouch L.A., Pitz E., Schuleri K.H., et al. Deficiency of neuronal nitric oxide synthase increases mortality and cardiac remodeling after myocardial infarction: role of nitroso-redox equilibrium. Circulation 2005, 112:3415-3422.
50. Vandsburger M.H., French B.A., Helm P.A., Roy R.J., Kramer C.M., Young A.A., et al. Multi-parameter in vivo cardiac magnetic resonance imaging demonstrates normal perfusion reserve despite severely attenuated beta-adrenergic functional response in neuronal nitric oxide synthase knockout mice. Eur Heart J 2007, 28:2792-2798.
51. Seddon M., Melikian N., Dworakowski R., Shabeeh H., Jiang B., Byrne J., et al. Effects of neuronal nitric oxide synthase on human coronary artery diameter and blood flow in vivo. Circulation 2009, 119:2656-2662.
52. Zhang Q., Scholz P.M., Pilzak A., Su J., Weiss H.R. Role of phospholamban in cyclic GMP mediated signaling in cardiac myocytes. Cell Physiol Biochem 2007, 20:157-166.
53. Brunner F., Andrew P., Wolkart G., Zechner R., Mayer B. Myocardial contractile function and heart rate in mice with myocyte-specific overexpression of endothelial nitric oxide synthase. Circulation 2001, 104:3097-3102.
54. Janssens S., Pokreisz P., Schoonjans L., Pellens M., Vermeersch P., Tjwa M., et al. Cardiomyocyte-specific overexpression of nitric oxide synthase 3 improves left ventricular performance and reduces compensatory hypertrophy after myocardial infarction. Circ Res 2004, 94:1256-1262.
55. Elrod J.W., Greer J.J., Bryan N.S., Langston W., Szot J.F., Gebregzlabher H., et al. Cardiomyocyte-specific overexpression of NO synthase-3 protects against myocardial ischemia-reperfusion injury. Arterioscler Thromb Vasc Biol 2006, 26:1517-1523.
56. Damy T., Ratajczak P., Robidel E., Bendall J.K., Olivero P., Boczkowski J., et al. Up-regulation of cardiac nitric oxide synthase 1-derived nitric oxide after myocardial infarction in senescent rats. FASEB J 2003, 17:1934-1936.
57. Takimoto E., Champion H.C., Li M., Ren S., Rodriguez E.R., Tavazzi B., et al. Oxidant stress from nitric oxide synthase-3 uncoupling stimulates cardiac pathologic remodeling from chronic pressure load. J Clin Invest 2005, 115:1221-1231.
58. Burkard N., Rokita A.G., Kaufmann S.G., Hallhuber M., Wu R., Hu K., et al. Conditional neuronal nitric oxide synthase overexpression impairs myocardial contractility. Circ Res 2007, 100:e32-e44.
59. Loyer X., Gomez A.M., Milliez P., Fernandez-Velasco M., Vangheluwe P., Vinet L., et al. Cardiomyocyte overexpression of neuronal nitric oxide synthase delays transition toward heart failure in response to pressure overload by preserving calcium cycling. Circulation 2008, 117:3187-3198.
60. Burkard N., Williams T., Czolbe M., Blomer N., Panther F., Link M., et al. Conditional overexpression of neuronal nitric oxide synthase is cardioprotective in ischemia/reperfusion. Circulation 2010, 122:1588-1603.
61. Beigi F., Oskouei B.N., Zheng M., Cooke C.A., Lamirault G., Hare J.M. Cardiac nitric oxide synthase-1 localization within the cardiomyocyte is accompanied by the adaptor protein, CAPON. Nitric Oxide 2009, 21:226-233.
62. Arnold W.P., Mittal C.K., Katsuki S., Murad F. Nitric oxide activates guanylate cyclase and increases guanosine 3':5'-cyclic monophosphate levels in various tissue preparations. Proc Natl Acad Sci U S A 1977, 74:3203-3207.
63. Francis S.H., Busch J.L., Corbin J.D., Sibley D. cGMP-dependent protein kinases and cGMP phosphodiesterases in nitric oxide and cGMP action. Pharmacol Rev 2010, 62:525-563.
64. Lee D.I., Vahebi S., Tocchetti C.G., Barouch L.A., Solaro R.J., Takimoto E., et al. PDE5A suppression of acute beta-adrenergic activation requires modulation of myocyte beta-3 signaling coupled to PKG-mediated troponin I phosphorylation. Basic Res Cardiol 2010, 105:337-347.
65. Castro L.R., Schittl J., Fischmeister R. Feedback control through cGMP-dependent protein kinase contributes to differential regulation and compartmentation of cGMP in rat cardiac myocytes. Circ Res 2010, 107:1232-1240.
66. Vila-Petroff M., Younes A., Egan J., Lakatta E.G., Sollott S.J. Activation of distinct cAMP-dependent and cGMP-dependent pathways by nitric oxide in cardiac myocytes. Circ Res 1999, 84:1020-1031.
67. Fischmeister R., Castro L.R.V., Abi-Gerges A., Rochais F., Jurevicius J., Leroy J., et al. Compartmentation of cyclic nucleotide signaling in the heart: the role of cyclic nucleotide phosphodiesterases. Circ Res 2006, 99:816-828.
68. Zaccolo M. Phosphodiesterases and compartmentalized cAMP signalling in the heart. Eur J Cell Biol 2006, 85:693-697.
69. Stangherlin A., Gesellchen F., Zoccarato A., Terrin A., Fields L.A., Berrera M., et al. cGMP signals modulate cAMP levels in a compartment-specific manner to regulate catecholamine-dependent signaling in cardiac myocytes. Circ Res 2011, 108:929-939.
70. Tolstykh T., Lee J., Vafai S., Stock J.B. Carboxyl methylation regulates phosphoprotein phosphatase 2A by controlling the association of regulatory B subunits. EMBO J 2000, 19:5682-5691.
71. Wu J., Tolstykh T., Lee J., Boyd K., Stock J.B., Broach J.R. Carboxyl methylation of the phosphoprotein phosphatase 2A catalytic subunit promotes its functional association with regulatory subunits in vivo. EMBO J 2000, 19:5672-5681.
72. Lima B., Forrester M.T., Hess D.T., Stamler J.S. S-nitrosylation in cardiovascular signaling. Circ Res 2010, 106:633-646.
73. Kohr M.J., Aponte A.M., Sun J., Wang G., Murphy E., Gucek M., et al. Characterization of potential S-nitrosylation sites in the myocardium. Am J Physiol Heart Circ Physiol 2011, 300:H1327-H1335.
74. Campbell D.L., Stamler J.S., Strauss H.C. Redox modulation of L-type calcium channels in ferret ventricular myocytes. Dual mechanism regulation by nitric oxide and S-nitrosothiols. J Gen Physiol 1996, 108:277-293.
75. 2+ channels by S-nitrosothiol nitric oxide donors. Circ Res 1997, 81:742-752.
76. Gonzalez D.R., Beigi F., Treuer A.V., Hare J.M. Deficient ryanodine receptor S-nitrosylation increases sarcoplasmic reticulum calcium leak and arrhythmogenesis in cardiomyocytes. Proc Natl Acad Sci U S A 2007, 104:20612-20617.
77. Fauconnier J., Thireau J., Reiken S., Cassan C., Richard S., Matecki S., et al. Leaky RyR2 trigger ventricular arrhythmias in Duchenne muscular dystrophy. Proc Natl Acad Sci U S A 2010, 107:1559-1564.
78. Bellinger A.M., Reiken S., Carlson C., Mongillo M., Liu X., Rothman L., et al. Hypernitrosylated ryanodine receptor calcium release channels are leaky in dystrophic muscle. Nat Med 2009, 15:325-330.
79. Canton M., Menazza S., Sheeran F.L., Polverino de Laureto P., Di Lisa F., Pepe S. Oxidation of myofibrillar proteins in human heart failure. J Am Coll Cardiol 2011, 57:300-309.
80. Viner R.I., Williams T.D., Schoneich C. Peroxynitrite modification of protein thiols: oxidation, nitrosylation, and S-glutathiolation of functionally important cysteine residue(s) in the sarcoplasmic reticulum Ca-ATPase. Biochemistry 1999, 38:12408-12415.
81. Zhang Y.H., Dingle L., Hall R., Casadei B. The role of nitric oxide and reactive oxygen species in the positive inotropic response to mechanical stretch in the mammalian myocardium. Biochim Biophys Acta 2009, 1787:811-817.
82. Kohr M.J., Wang H., Wheeler D.G., Velayutham M., Zweier J.L., Ziolo M.T. Biphasic effect of SIN-1 is reliant upon cardiomyocyte contractile state. Free Radic Biol Med 2008, 45:73-80.
83. Kohr M.J., Traynham C.J., Roof S.R., Davis J.P., Ziolo M.T. cAMP-independent activation of protein kinase A by the peroxynitrite generator SIN-1 elicits positive inotropic effects in cardiomyocytes. J Mol Cell Cardiol 2010, 48:645-648.
84. Brennan J.P., Bardswell S.C., Burgoyne J.R., Fuller W., Schroder E., Wait R., et al. Oxidant-induced activation of type I protein kinase A is mediated by RI subunit interprotein disulfide bond formation. J Biol Chem 2006, 281:21827-21836.
85. Burgoyne J.R., Madhani M., Cuello F., Charles R.L., Brennan J.P., Schroder E., et al. Cysteine redox sensor in PKGIa enables oxidant-induced activation. Science 2007, 317:1393-1397.
86. Burgoyne J.R., Eaton P. Transnitrosylating nitric oxide species directly activate type I protein kinase A, providing a novel adenylate cyclase-independent cross-talk to β-adrenergic-like signaling. J Biol Chem 2009, 284:29260-29268.
87. Foley T.D., Petro L.A., Stredny C.M., Coppa T.M. Oxidative inhibition of protein phosphatase 2A activity: role of catalytic subunit disulfides. Neurochem Res 2007, 32:1957-1964.
88. Foley T.D., Melideo S.L., Healey A.E., Lucas E.J., Koval J.A. Phenylarsine oxide binding reveals redox-active and potential regulatory vicinal thiols on the catalytic subunit of protein phosphatase 2A. Neurochem Res 2011, 36:232-240.
89. Kim Y.M., Guzik T.J., Zhang Y.H., Zhang M.H., Kattach H., Ratnatunga C., et al. A myocardial Nox2 containing NAD(P)H oxidase contributes to oxidative stress in human atrial fibrillation. Circ Res 2005, 97:629-636.
90. Dumitrescu C., Biondi R., Xia Y., Cardounel A.J., Druhan L.J., Ambrosio G., et al. Myocardial ischemia results in tetrahydrobiopterin (BH4) oxidation with impaired endothelial function ameliorated by BH4. Proc Natl Acad Sci U S A 2007, 104:15081-15086.
91. Silberman G.A., Fan T.-H.M., Liu H., Jiao Z., Xiao H.D., Lovelock J.D., et al. Uncoupled cardiac nitric oxide synthase mediates diastolic dysfunction. Circulation 2010, 121:519-528.
92. Reilly S.N., Jayaram R., Nahar K., Antoniades C., Verheule S., Channon K.M., Alp N.J., Schotten U., Casadei B. Atrial sources of reactive oxygen species vary with the duration and substrate of atrial fibrillation: implications for the antiarrhythmic effect of statins. Circulation 2011, 124(10). (Sep 6):1107-17.
93. Steppan J., Ryoo S., Schuleri K.H., Gregg C., Hasan R.K., White A.R., et al. Arginase modulates myocardial contractility by a nitric oxide synthase 1-dependent mechanism. Proc Natl Acad Sci U S A 2006, 103:4759-4764.
94. Lin M.I., Fulton D., Babbitt R., Fleming I., Busse R., Pritchard K.A., et al. Phosphorylation of threonine 497 in endothelial nitric-oxide synthase coordinates the coupling of l-arginine metabolism to efficient nitric oxide production. J Biol Chem 2003, 278:44719-44726.
95. Chen C.-A., Wang T.-Y., Varadharaj S., Reyes L.A., Hemann C., Talukder M.A.H., et al. S-glutathionylation uncouples eNOS and regulates its cellular and vascular function. Nature 2010, 468:1115-1118.